YIH
CBIO

Y-Intercept (HK)’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Y-Intercept (HK)’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-431
Closed -$129K – 1572
2024
Q1 		$129K Buy
431
+165
+62% +$49.5K 0.01% 1243
2023
Q4 		$62.7K Buy
+266
New +$62.7K 0.01% 1142